These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3463778)

  • 41. DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicin.
    Ando S; Kamiya K; Yoshimura T; Tsutani H; Ueda T; Uchida M; Nakamura T; Uchino H
    Anticancer Res; 1988; 8(3):409-15. PubMed ID: 3164610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the effects of anthracyclines on mitochondrial respiration in vitro.
    Solaini G; Ronca G; Bertelli A
    Drugs Exp Clin Res; 1985; 11(2):115-21. PubMed ID: 3869803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo.
    Tapiero H; Munck JN; Fourcade A
    Drugs Exp Clin Res; 1986; 12(1-3):257-64. PubMed ID: 3460752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro sensitivity of myeloblast clonogenic cells to doxorubicin, aclacinomycin A, and 4'-O-tetrapyranyl-doxorubicin: correlations with clinical responses.
    Georgoulias V; Iskandar YL; Amesland F; Ribaud P; Mathé G; Jasmin C
    J Clin Oncol; 1984 Nov; 2(11):1215-22. PubMed ID: 6593437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
    Coley HM; Twentyman PR; Workman P
    Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.
    Han G; Israel M; Seshadri R; Dalton JT; Sweatman TW
    Cancer Chemother Pharmacol; 1996; 37(5):472-8. PubMed ID: 8599871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
    Marie JP; Thevenin D; Zittoun R
    Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
    Miller AA; Schmidt CG
    Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacokinetics and disposition of a new antitumor antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after multiple administration].
    Tone H; Iguchi H; Shomura T; Komiya I; Nishio M
    Jpn J Antibiot; 1986 Feb; 39(2):629-37. PubMed ID: 3712762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer.
    Mader RM; Zilg H; Schlappack O; Steger GG; Baur M; Greifenberg B; Heberle U; Dittrich C
    Cancer Chemother Pharmacol; 1995; 37(1-2):91-6. PubMed ID: 7497603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
    Shinkai H; Takahashi H; Miyamoto K; Uchida T; Tokiwa T
    Cancer Chemother Pharmacol; 1996; 38(5):417-24. PubMed ID: 8765434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence of circulating 7-deoxyaglycone metabolites of 4'-deoxydoxorubicin in man.
    Cummings J; Kerr DJ; Kaye SB
    Cancer Chemother Pharmacol; 1987; 20(3):263-4. PubMed ID: 3677300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radical dimer rescue of toxicity and improved therapeutic index of adriamycin in tumor-bearing mice.
    Averbuch SD; Gaudiano G; Koch TH; Bachur NR
    Cancer Res; 1985 Dec; 45(12 Pt 1):6200-4. PubMed ID: 4063971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective distribution of aclarubicin to regional lymph nodes with a new dosage form: aclarubicin adsorbed on activated carbon particles.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Matsumoto S; Muranishi S
    Anticancer Drugs; 1991 Jun; 2(3):261-6. PubMed ID: 1802020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Enhanced effect of hepatic arterial infused anticancer drugs on rabbit VX-2 carcinoma by means of combination with Lipiodol. Adriamycin versus Lipiodol adriamycin sandwich method and adriamycin suspended in a Lipiodol].
    Hoshino M; Koyama Y; Sugano K; Kanno M; Satou N; Abe R
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2810-3. PubMed ID: 2551224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice.
    Bolanowska W; Gessner T
    Xenobiotica; 1982 Feb; 12(2):125-36. PubMed ID: 7090422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pharmacokinetics and metabolism of anthracyclines in man].
    Robert J
    Pathol Biol (Paris); 1987 Jan; 35(1):27-30. PubMed ID: 3550609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1669-74. PubMed ID: 6591857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
    Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.
    Yokoyama M; Okano T; Sakurai Y; Ekimoto H; Shibazaki C; Kataoka K
    Cancer Res; 1991 Jun; 51(12):3229-36. PubMed ID: 2039998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.